Skip to content

GPS Project Evaluation of the Impact of the Reorganization of Work Into a Family Medicine Group on Pharmacotherapy and Support for the Autonomy of Seniors With Major Neurocognitive Disorders

Major Neurocognitive Disorder

The model of care tested in the GPS project aims to optimize pharmacotherapy for seniors undergoing cognitive assessment or suffering from major neurocognitive disorder (MCND) at home. The goal is to reduce polymedication, inappropriate medications and the treatment burden of seniors and to maintain their cognitive health, quality of life and autonomy. The intervention will include knowledge exchange sessions with nurses, pharmacists, and doctors in FMGs, and increased collaboration between these professionals and home care services teams. Other goal is to increase the satisfaction of the seniors, their families, and the professionals involved in the GPS project.

null

Participation Requirements

  • Sex:

    ALL

  • Eligible Ages:

    65 and up

Participation Criteria

Inclusion Criteria:

* All seniors (65 years of age or older) undergoing cognitive evaluation OR referred to a memory clinic OR having been diagnosed with cognitive impairment within the last year OR with MCND and followed up at home AND,
* referred to the pharmacist, for the FMGs exposed
* taking prescription medications

Exclusion Criteria:

* Seniors in palliative care OR
* unable to answer questionnaires in French AND without a caregiver.

Study Location

GMF Abénakis
GMF Abénakis
Saint-Georges, Quebec
Canada

Contact Study Team

Primary Contact

Line Guénette, Ph.D

[email protected]
418-682-7511
GMF Bordeaux-Cartierville
GMF Bordeaux-Cartierville
Montréal, Quebec
Canada

Contact Study Team

Primary Contact

Line Guénette, Ph.D

[email protected]
418-682-7511
Study Sponsored By
CHU de Quebec-Universite Laval
Participants Required
More Information
Study ID: NCT04889794